Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesMolecular ImagingPET scans tie fast food to altered blood flow in the heartUltraprocessed foods may acutely affect vascular and brain function, researchers report.AIAI boosts rads' identification of incidental PE on CT imagingPractice ManagementHow are technologists dealing with higher vacancy rates?UltrasoundUltrasound screening for vasa previa tied to better pregnancy outcomesDigital X-RayAI could be cost-effective for osteoporosis screening
